// App-Quantinova.ai

2556 : Prognostic Significance Of Copy Number Alterations In B-Lineage Adult Acute Lymphoblastic Leukemia Patients Enrolled In Risk-Adapted Protocols From The Pethema Group

Researchers

Presenter

  • Jordi Ribera

Principal Investigators

  • Mireia Morgades

  • Mar Tormo

  • Maria Collado

  • Joaquin Martinez

  • Pilar Martinez-Sanchez

  • Jesus Maria Hernandez-Rivas

  • Marcos Gonzalez

  • Jose Gonzalez-Campos

  • Pablo Trujillo

  • Pere Barba

  • Neus Ruiz-Xiville

  • Ramon Guardia

  • Isabel Granada

  • Silvia Marce

  • Marta Cabezon

  • Eula lia Genesca

  • Francesc Sole

  • Jordi Junca

  • Fuensanta Milla

  • Evarist Feliu

  • Josep-Maria Ribera

  • Josep Sarra

  • Ines Gomez-Segui

  • Pau Montesinos

  • Marta Pratcorona

  • Jordi Esteve

  • Josep F. Nomdedeu

  • Salut Brunet

Medical Centers

  • Josep Carreras Leukemia Research Institute, Barcelona, Spain

  • MDS Research Group, Institut de Recerca Contra la Leucemia Josep Carreras, ICO-Hospital Germans Trias i Pujol, Universitat Autnoma de Barcelona, Badalona, Spain

  • Department of Haematology, Hospital Universitario de Salamanca, Salamanca, Spain

  • PETHEMA Group, Spanish Society of Hematology, Sevilla, Spain

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • MDS Research Group, Institut de Recerca Contra la Leucemia Josep Carreras, ICO-Hospital Germans Trias i Pujol, Universitat Autnoma de Barcelona, Badalona, Spain

  • PETHEMA Group, Spanish Society of Hematology, Sevilla, Spain

  • Hospital Clinico Universitario, Malaga, Spain

  • Department of Hematology, ICO-Germans Trias i Pujol Hospital. Josep Carreras Leukemia Research Institute. Universitat Autnoma de Barcelona, Badalona, Spain

  • Hematology Service, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucemia Josep Carreras, Universitat Autnoma de Barcelona, Badalona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Glucocorticoid resistance

Biomarkers

  • Breakpoint Cluster Region

  • Paired box 5

  • CREB-binding protein

  • Cyclin Dependent Kinase Inhibitor 2A

  • Retinoblastoma protein

  • ETV6-RUNX1

  • Histone-lysine N-methyltransferase 2A

  • Immunoglobulin heavy-chain variable region gene

  • Lymphocyte count

  • Metastasis Associated 1

  • Tumor protein p53

  • White Blood Cell

Drug/Treatment

  • Glucocorticoid

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved